InterCare Valuation
| ICCO Stock | USD 0.0001 0.00 0.00% |
InterCare seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of InterCare DX from evaluating the firm fundamentals such as Current Valuation of 12.9 M, return on asset of 1.99, and Price To Sales of 1.61 X as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that InterCare's price fluctuation is very steady at this time. Calculation of the real value of InterCare DX is based on 3 months time horizon. Increasing InterCare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since InterCare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of InterCare Pink Sheet. However, InterCare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 |
The intrinsic value of InterCare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence InterCare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of InterCare DX helps investors to forecast how InterCare pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of InterCare more accurately as focusing exclusively on InterCare's fundamentals will not take into account other important factors: About InterCare Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of InterCare DX. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of InterCare DX based exclusively on its fundamental and basic technical indicators. By analyzing InterCare's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of InterCare's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of InterCare. We calculate exposure to InterCare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of InterCare's related companies.InterCare DX, Inc. operates as a biomedical and other software products development and services company. InterCare DX, Inc. was founded in 1991 and is based in Hawthorne, California. Intercare operates under Health Information Services classification in the United States and is traded on OTC Exchange.
8 Steps to conduct InterCare's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates InterCare's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct InterCare's valuation analysis, follow these 8 steps:- Gather financial information: Obtain InterCare's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine InterCare's revenue streams: Identify InterCare's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research InterCare's industry and market trends, including the size of the market, growth rate, and competition.
- Establish InterCare's growth potential: Evaluate InterCare's management, business model, and growth potential.
- Determine InterCare's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate InterCare's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
InterCare Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Quarterly Earnings Growth Y O Y | 22.808 | |
| Retained Earnings | -5.5 M | |
| Quarterly Revenue Growth Y O Y | 5.768 |
Other Information on Investing in InterCare Pink Sheet
InterCare financial ratios help investors to determine whether InterCare Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in InterCare with respect to the benefits of owning InterCare security.